About Cesca Therapeutics
Cesca Therapeutics is a company based in Rancho Cordova (United States) founded in 1986.. Cesca Therapeutics has completed 1 acquisition, including SynGen. Cesca Therapeutics operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Rancho Cordova, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Totipotentsc Scientific Product Private Limited
- Date of Incorporation 28 Mar, 2008
- Jurisdiction Gurugram, Haryana, India
-
Annual Revenue
$336.78 K (USD)-20.7as on Mar 31, 2017
-
Net Profit
$-80.18 K (USD)8.35as on Mar 31, 2017
-
EBITDA
$-103.03 K (USD)-13.62as on Mar 31, 2017
-
Latest Funding Round
$800 K (USD), Post-IPO
Feb 13, 2019
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
3 people
Operations Team
1 people
Sr. Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Cesca Therapeutics
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $800,000
-
First Round
First Round
(01 Jun 2002)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Post-IPO - Cesca Therapeutics | Valuation |
investors |
|
| Nov, 2017 | Amount | Post-IPO - Cesca Therapeutics | Valuation |
investors |
|
| Feb, 2016 | Amount | Post-IPO - Cesca Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cesca Therapeutics
Cesca Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boyalife Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cesca Therapeutics
Cesca Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SynGen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops cell separation tools and accessories
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cesca Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cesca Therapeutics Comparisons
Competitors of Cesca Therapeutics
Cesca Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cesca Therapeutics
Frequently Asked Questions about Cesca Therapeutics
When was Cesca Therapeutics founded?
Cesca Therapeutics was founded in 1986 and raised its 1st funding round 16 years after it was founded.
Where is Cesca Therapeutics located?
Cesca Therapeutics is headquartered in Rancho Cordova, United States. It is registered at Rancho Cordova, California, United States.
What is the annual revenue of Cesca Therapeutics?
Annual revenue of Cesca Therapeutics is $336.78K as on Mar 31, 2017.
What does Cesca Therapeutics do?
Cesca Therapeutics is engaged in the development of cell-based therapeutics as regenerative medicine. It was formed by the merger of Thermogenesis which supplies a supplier of enabling technologies for the processing and storage of stem cells and TotipotentRx which develops cell-based therapies. Its lead therapeutic technology platform SurgWerks harvests, selects and delivers a dose of autologous bone marrow derived or peripheral blood-derived cells and proteins. The technology is currently in clinical trials as a potential treatment for acute myocardial infarction, critical limb ischemia, and orthopedic injuries. It also manufactures devices created specifically for regenerative medicine. Besides, it also provides cell manufacturing and banking services.
Who are the top competitors of Cesca Therapeutics?
Cesca Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
How many acquisitions has Cesca Therapeutics made?
Cesca Therapeutics has made 1 acquisition, including SynGen.
Who are Cesca Therapeutics's investors?
Cesca Therapeutics has 1 investor. Key investors include Boyalife Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.